Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYRN

Cyren (CYRN) Stock Price, News & Analysis

Cyren logo

About Cyren Stock (NASDAQ:CYRN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.21
$0.92
52-Week Range
N/A
Volume
1.15 million shs
Average Volume
1.43 million shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CYREN Ltd. engages in the provision of cloud delivered Software-as-a-Service cybersecurity solutions that protect businesses, employees and customers against threats from email, files, and the web. It operates through the following geographical segments: Israel, United States, Germany and Other. Its products include inbox security for office 365, threat indepth, and incident response service The company was founded by Amir Lev, Gideon Mantel, and Nahum Sharfman on February 10, 1991 and is headquartered in Herzliya, Israel.

Receive CYRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter.

CYRN Stock News Headlines

Peyto Exploration&Development Corp (PEY)
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Why Is Cyren (CYRN) Stock Down 27% Today?
Cyren Announces Nasdaq Delisting Determination
Cyren Announces Liquidation
Why Is Cyren (CYRN) Stock Up 43% Today?
See More Headlines

CYRN Stock Analysis - Frequently Asked Questions

Cyren Ltd. (NASDAQ:CYRN) issued its quarterly earnings data on Monday, November, 15th. The technology company reported ($0.06) EPS for the quarter, hitting the consensus estimate of ($0.06). The technology company had revenue of $7.46 million for the quarter. Cyren had a negative net margin of 123.96% and a negative trailing twelve-month return on equity of 206.16%.

Cyren subsidiaries include eleven GmbH, FRISK Software International, Authentium, Wingtra, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., and Cyren UK Ltd..

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyren investors own include Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT), Acasti Pharma (ACST), iBio (IBIO), Oragenics (OGEN) and OpGen (OPGN).

Company Calendar

Last Earnings
11/15/2021
Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRN
Employees
200
Year Founded
1991

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.04 million
Net Margins
-123.96%
Pretax Margin
-94.37%

Debt

Sales & Book Value

Annual Sales
$31.19 million
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
N/A

Miscellaneous

Free Float
7,539,000
Market Cap
$1.70 million
Optionable
Not Optionable
Beta
0.83

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:CYRN) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners